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ABSTRACT Streptomyces sp. strain SM8, isolated from Haliclona simulans, possesses
antifungal and antibacterial activities and inhibits the calcineurin pathway in yeast.
The draft genome sequence is 7,145,211 bp, containing 5,929 predicted coding se-
quences. Several secondary metabolite biosynthetic gene clusters are present, en-
coding known and novel metabolites, including antimycin.
Marine organisms are a rich source of novel secondary metabolites, with over 1,000novel marine compounds discovered in 2015 alone (1). Sponges are a signiﬁcant
source of secondary metabolites, and more than 190 different metabolites have been
isolated from the genus Haliclona alone (2). Many of the metabolites isolated from
marine sponges are believed to be of microbial origin, suggesting symbiotic relation-
ships between sponges and associated bioactive-producing microorganisms (3).
In a study of bacteria isolated from the marine sponge Haliclona simulans collected
from the west coast of Ireland, up to 50% of bacteria were found to produce antibiotic
activity against medically important pathogens, such as methicillin-resistant Staphylo-
coccus aureus (MRSA) (4). In an initial screen, the Streptomyces sp. strain SM8 showed
antibacterial and strong antifungal activities (4). Nuclear magnetic resonance (NMR)
analysis of the active fractions proved that hydroxylated saturated fatty acids were the
major components present in the antibacterial fractions (5). Subsequent screening
showed that this strain also produced compounds that inhibited the calcineurin
pathway in Saccharomyces cerevisiae (6). Metabolic proﬁling of the compounds pro-
duced by the organism identiﬁed antimycin as one of the main products with antifun-
gal activity (5). The genome sequence of strain SM8 was determined to facilitate the
identiﬁcation of the range of bioactive compounds produced by the organism and of
further heterologous expression of gene clusters encoding products of interest using
the transformation-association recombination (TAR) cloning technique (7, 8).
Genomic DNA (gDNA) was obtained as previously described (5). The nucleotide
sequence was generated from a fragment library using the GS FLX Titanium system
(Roche), resulting in 229,280 reads and 94,668,678 bp. The assembly of the contigs was
performed using i) GS De Novo Assembler v2.3 (Roche) software for the de novo
assembly of reads and then ii) MeDuSa software v1.6 for the reference-based assembly
of scaffolds (9), using as the reference the top 3 complete genomes that shared the
highest 16S rRNA gene sequence similarities in NCBI’s GenBank database, namely,
Streptomyces sampsonii strain KJ40 (GenBank accession no. NZ_CP016824), Streptomy-
ces albus strain SM254 (NZ_CP014485), and S. albus strain J1074 (NC_020990) (10–13).
The quality of the ﬁnal assembly was evaluated with QUAST v4.5 and checkM software,
resulting in 11 scaffolds of500 bp, a length of 7,145,211 bp, a GC content of 73.33%,
and an estimated genome completion of 96.11% (14, 15). The draft sequence was
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annotated using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) v4.3, which
predicted 5,929 coding sequences (CDSs), 3 rRNAs, and 61 tRNAs (16).
Analysis for the prediction of secondary metabolite gene clusters using antiSMASH
v4.0.2 identiﬁed several gene clusters encoding polyketide synthases (PKS), nonribo-
somal peptide synthetases (NRPS), PKS/NRPS hybrids, terpene biosynthesis, and sid-
erophores (17). The complete gene cluster for the biosynthesis of antimycin—a com-
pound which was previously identiﬁed by mass spectrometry analysis (5)—was also
identiﬁed using antiSMASH and manually curated. Knowledge of the genetic basis of
secondary metabolism in Streptomyces sp. strain SM8 will lead to further characteriza-
tion of the compounds responsible for the wide range of biological activities present.
Accession number(s). This whole-genome shotgun project has been deposited in
DDBJ/ENA/GenBank under the accession no. AMPN00000000. The version described in
this paper is the second version, AMPN02000000.
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